본문

  1. Home
48 Results:AA:MAN Z PP:ELSEVIER INC 0.118 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
A novel locus on the X chromosome regulates post-maturity bone density changes in mice
A novel locus on the X chromosome regulates post-maturity bone density changes in mice
D. Szumska, | Elsevier Inc | 2007 ,
2
The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro
The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro
Val Mann,, | Elsevier Inc | 2007 ,
3
Letter to the Editor re: “Incidence and characteristics of falls leading to hip fracture in Iranian population�? by Abolhassani et al. BONE 2006:39;408–13
Letter to the Editor re: “Incidence and characteristics of falls leading to hip fracture in Iranian population�? by Abolhassani et al. BONE 2006:39;408–13
Formiga, F., | Elsevier Inc | 2007 ,
4
1α,25-Dihydroxy-2β(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora
1α,25-Dihydroxy-2β(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora
Cao, Y., | Elsevier Inc | 2007 ,
5
Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men
Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men
Douglas P. Kiel,, | Elsevier Inc | 2007 ,
6
Clinical risk factors for fracture in postmenopausal Canadian women: A population-based prevalence study
Clinical risk factors for fracture in postmenopausal Canadian women: A population-based prevalence study
Leslie, W. D., | Elsevier Inc | 2007 ,
7
High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse
High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse
Yang Li, C., | Elsevier Inc | 2005 ,
8
Human parathyroid hormone (1???34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora
Human parathyroid hormone (1???34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora
Komatsubara, S., | Elsevier Inc | 2005 ,
9
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
Pierre D Delmas,, | Elsevier Inc | 2008 ,
10
Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment
Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment
Mussa, A., | Elsevier Inc | 2010 ,
처음12345이후마지막